Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

President and CEO

Chief Financial Officer

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase I/Ib clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas, as well as designed to inhibit the proliferation of certain malignant T-cells; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase II clinical trial for patients with advanced or refractory renal cell cancer. Its preclinical stage products include CPI-182, an antibody designed to block inflammation and myeloid suppression; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncol...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-06	Premium	bought	Premium	Premium	Premium	See Remarks
2024-05-06	Premium	bought	Premium	Premium	Premium	President and CEO
2023-05-15	Premium	bought	Premium	Premium	Premium	-
2022-12-20	Premium	bought	Premium	Premium	Premium	See Remarks
2022-12-14	Premium	bought	Premium	Premium	Premium	President and CEO
2022-12-14	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-12-13	Premium	bought	Premium	Premium	Premium	President and CEO
2022-12-13	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-09-28	Premium	bought	Premium	Premium	Premium	President and CEO
2022-09-20	Premium	bought	Premium	Premium	Premium	President and CEO
2022-06-27	Premium	bought	Premium	Premium	Premium	President and CEO
2022-06-24	Premium	bought	Premium	Premium	Premium	President and CEO
2022-06-06	Premium	bought	Premium	Premium	Premium	President and CEO
2022-06-02	Premium	bought	Premium	Premium	Premium	President and CEO
2022-03-31	Premium	bought	Premium	Premium	Premium	President and CEO
2022-03-17	Premium	bought	Premium	Premium	Premium	President and CEO
2022-03-17	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-03-16	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-03-15	Premium	bought	Premium	Premium	Premium	President and CEO
2021-10-01	Premium	sold	Premium	Premium	Premium	-
2021-09-30	Premium	sold	Premium	Premium	Premium	-
2021-09-20	Premium	sold	Premium	Premium	Premium	-
2021-09-20	Premium	sold	Premium	Premium	Premium	-
2021-08-20	Premium	bought	Premium	Premium	Premium	President and CEO
2021-05-04	Premium	bought	Premium	Premium	Premium	President and CEO

CRVS - Corvus Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for CRVS